This compound is a pharmaceutical intermediate cataloged for use in research related to the hepatitis C virus (HCV). It is a small-molecule reagent with structural features including multiple ring systems and polar functional groups, commonly supplied for laboratory-scale synthesis studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing HCV-IN-31?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-2-(2-Hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester
pharmaceutical intermediate
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate
pharmaceutical intermediate
5-(4-Bromophenyl)furfural
pharmaceutical intermediate
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-L-ornithine
pharmaceutical intermediate
(2R,3R,4R,5R)-5-[2-amino-6-(methylamino)purin-9-yl]-4-fluoro-2-(hydroxymethyl)-4-methyloxolan-3-ol
HPINXBYYNVDDEB-GSWPYSDESA-N
C[C@]1([C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)N)NC)CO)O)F
Sourcing HCV-IN-31?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.